INSULIN-DEPENDENT DIABETES IN THE NOD MOUSE MODEL .1. DETECTION AND CHARACTERIZATION OF AUTOANTIBODY BOUND TO THE SURFACE OF PANCREATIC BETA-CELLS PRIOR TO DEVELOPMENT OF THE INSULITIS LESION IN PREDIABETIC NOD MICE
Dc. Shieh et al., INSULIN-DEPENDENT DIABETES IN THE NOD MOUSE MODEL .1. DETECTION AND CHARACTERIZATION OF AUTOANTIBODY BOUND TO THE SURFACE OF PANCREATIC BETA-CELLS PRIOR TO DEVELOPMENT OF THE INSULITIS LESION IN PREDIABETIC NOD MICE, Autoimmunity, 15(2), 1993, pp. 123-135
Type I, insulin-dependent diabetes (IDD) results from an autoimmune re
sponse against the insulin producing pancreatic beta cells. This autoi
mmune reaction involves both humoral and cell-mediated factors; nevert
heless, the relative role of each remains unresolved. Furthermore, whi
le adoptive transfer experiments have provided evidence for the role o
f T cells in beta cell destruction, the specific events which initiate
leukocyte migration into the islets (insulitis) are unknown. Earlier
studies indicated that NOD pancreatic beta cells may bind small amount
s of autoantibody. Because of the possible importance of an early humo
ral response to the initiation of insulitis and subsequent disease, we
have investigated a number of aspects of this phenomenon to determine
the nature and specificity of the early autoantibodies as well as the
time at which autoantibody binds to beta cells. Results of this study
demonstrate that NOD/Uf mice are sensitized to islet-cell associated
antigens, including GAD, prior to the first appearance of insulitis; t
hat a small percentage of the beta cells of NOD/Uf mice have autoantib
ody bound to their surface prior to insulitis; that sera collected fro
m preinsulitis NOD/Uf mice contain autoantibodies which will bind to b
eta cells of both IDD-prone and IDD-resistant mice; and that the autoa
ntibodies which bind pancreatic beta cells are predominantly IgM with
lesser amounts of IgG and IgA. These findings suggest that, in the nat
ural course of IDD, insulitis may develop in response to an initial au
toantibody-mediated injury of beta cells.